SEC Form 4 · accession 0001104659-16-140255
PRA Health Sciences, Inc. · PRAH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Linda Baddour
Officer — Executive VP & CFO
Period of report
Aug 15, 2016
Accepted (ET)
Aug 17, 2016 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613859
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2016 | M | 69,380 | $2.94 | A | 69,380 | D | |
| Common Stock | Aug 15, 2016 | S | 69,380 | $52.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.94 | Aug 15, 2016 | M | 69,380 | D | — | Dec 21, 2017 | Common Stock | 69,380 | 108,129 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2The options vested on September 23, 2013.